Stockreport

Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property [Yahoo! Finance]

NORTHWEST BIOTHRPUTCS INC  (NWBO) 
US:NASDAQ Investor Relations: nwbio.com/investors-media
PDF BETHESDA, Md. June 17, 2024 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax ® personalized immune therapies [Read more]